Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.

Winnie Yeo; Tony S K Mok; Kin K Tse; Wing H Kwan; Kwok C Lam; Wing M Ho; Samuel K W Chiu; Anthony T C Chan; Thomas W T Leung; Frankie K F Mo

doi:10.1097/00001813-200207000-00013

Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/942DF299

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/942DF299.svg?ark=w1%2F20260515%2F942DF299)](https://nobleid.org/work/w1/20260515/942DF299)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/942DF299

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/942DF299.svg?ark=w1%2F20260515%2F942DF299)](https://nobleid.org/work/w1/20260515/942DF299)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work